CYSTADROPS
Google image searchProduct monograph
Active ingredient
cysteamine (cysteamine hydrochloride), 0.37 %/W/W
DIN: 02485605
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: RECORDATI RARE DISEASES CANADA INC
Date: 15-MAY-2019
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01X — OTHER OPHTHALMOLOGICALS (ATC, ATC/DDD)
- S01XA — Other ophthalmologicals (ATC, ATC/DDD)
- S01XA21 — MERCAPTAMINE (ATC/DDD)
